Knockout of Angiotensin AT2 receptors accelerates healing but impairs quality

Mahya Faghih1, Sayed M Hosseini2, Barbara Smith3

  • 1Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.

Aging
|January 6, 2016
PubMed

Insights

Disrupting angiotensin type 2 receptors (AT2R) accelerates wound healing rate but impairs skin quality. This suggests AT2R plays a complex role in the wound repair process, impacting both speed and integrity.

Area of Science:

  • Biomedical Science
  • Dermatology
  • Wound Healing Research

Background:

  • Wound healing is critical in older adults, with angiotensin type 1 receptors (AT1R) implicated in impaired repair.
  • The biological functions of angiotensin type 2 receptors (AT2R) in wound healing remain less understood.

Purpose of the Study:

  • To investigate the effects of genetically disrupting AT2R on the rate and quality of wound healing.
  • To elucidate the role of AT2R in different phases of the wound repair process.

Main Methods:

  • Utilized genetically modified mice lacking AT2R (AT2R-/-) for wound healing studies.
  • Compared wound closure rates and skin quality in AT2R-/- mice against control groups (C57/BL6 and AT1R-/- mice).
  • Analyzed the expression of AT1R, TGFβ1, and TGFβ2 during wound healing phases.

Main Results:

  • AT2R disruption led to delayed healing during the early inflammatory phase but accelerated healing in later proliferation and remodeling stages.
  • Fifty percent of AT2R-/- mice achieved complete wound closure by day 12, unlike control groups.
  • Increased expression of AT1R, TGFβ1, and TGFβ2 was observed in AT2R-/- mice during proliferative and remodeling phases.
  • Despite faster closure, AT2R-/- mice exhibited more fragile healed skin.

Conclusions:

  • Absence of AT2R accelerates wound healing rate but compromises the quality and integrity of the healed skin.
  • AT2R influences wound healing rate differentially across healing phases.
  • Understanding the roles of both AT1R and AT2R is crucial for developing targeted interventions for wound repair, particularly in the elderly.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K